Pegaspargase Bulk

Pegaspargase is a PEGylated form of L-Asparaginase engineered for extended plasma half-life and reduced immunogenicity compared to native asparaginase formulations. It functions by depleting circulating L-asparagine selectively targeting leukemic cells that lack the ability to synthesize this amino acid independently making it a preferred therapeutic option in ALL treatment protocols including first-line and relapsed/refractory settings.

Manufactured under WHO-GMP conditions and compliant with ICH quality guidelines, this bulk API is produced through a validated conjugation and purification process. Each batch is rigorously tested to ensure consistent PEGylation profile, enzymatic activity, ultra-low endotoxin levels and full documentation readiness for global regulatory submissions.